Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.910
-0.020 (-1.04%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $451.20 million. The enterprise value is $585.70 million.

Market Cap 451.20M
Enterprise Value 585.70M

Important Dates

The last earnings date was Thursday, March 13, 2025, before market open.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

AKBA has 236.23 million shares outstanding. The number of shares has increased by 12.53% in one year.

Current Share Class 236.23M
Shares Outstanding 236.23M
Shares Change (YoY) +12.53%
Shares Change (QoQ) +3.97%
Owned by Insiders (%) 2.43%
Owned by Institutions (%) 28.51%
Float 230.49M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.54
Forward PS 2.40
PB Ratio -9.13
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.66
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.41

Current Ratio 1.41
Quick Ratio 1.07
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.54

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -12.49%
Return on Invested Capital (ROIC) -22.81%
Return on Capital Employed (ROCE) -33.06%
Revenue Per Employee $884,972
Profits Per Employee -$383,481
Employee Count 181
Asset Turnover 0.69
Inventory Turnover 1.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.51% in the last 52 weeks. The beta is 0.94, so AKBA's price volatility has been similar to the market average.

Beta (5Y) 0.94
52-Week Price Change -14.51%
50-Day Moving Average 2.08
200-Day Moving Average 1.65
Relative Strength Index (RSI) 46.07
Average Volume (20 Days) 5,763,606

Short Selling Information

The latest short interest is 14.98 million, so 6.34% of the outstanding shares have been sold short.

Short Interest 14.98M
Short Previous Month 14.45M
Short % of Shares Out 6.34%
Short % of Float 6.50%
Short Ratio (days to cover) 5.03

Income Statement

In the last 12 months, AKBA had revenue of $160.18 million and -$69.41 million in losses. Loss per share was -$0.33.

Revenue 160.18M
Gross Profit 134.03M
Operating Income -46.21M
Pretax Income -40.44M
Net Income -69.41M
EBITDA -8.70M
EBIT -46.21M
Loss Per Share -$0.33
Full Income Statement

Balance Sheet

The company has $51.87 million in cash and $188.73 million in debt, giving a net cash position of -$136.86 million or -$0.58 per share.

Cash & Cash Equivalents 51.87M
Total Debt 188.73M
Net Cash -136.86M
Net Cash Per Share -$0.58
Equity (Book Value) -49.19M
Book Value Per Share -0.22
Working Capital 32.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.66 million and capital expenditures -$33,000, giving a free cash flow of -$40.69 million.

Operating Cash Flow -40.66M
Capital Expenditures -33,000
Free Cash Flow -40.69M
FCF Per Share -$0.17
Full Cash Flow Statement

Margins

Gross margin is 83.68%, with operating and profit margins of -28.85% and -43.33%.

Gross Margin 83.68%
Operating Margin -28.85%
Pretax Margin -43.33%
Profit Margin -43.33%
EBITDA Margin -5.43%
EBIT Margin -28.85%
FCF Margin n/a

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.53%
Shareholder Yield -12.53%
Earnings Yield -15.46%
FCF Yield -9.07%

Analyst Forecast

The average price target for AKBA is $6.75, which is 253.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.75
Price Target Difference 253.40%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 42.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AKBA has an Altman Z-Score of -9.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -9.75
Piotroski F-Score 4